Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Pulmonology Reports
Published in: Current Pulmonology Reports 4/2015

01-12-2015 | Smoking Cessation (S Veeraraghavan, Section Editor)

Computed tomography of smoking-related lung disease: review and update

Authors: Karen S. Zheng, Travis S. Henry, Brent P. Little

Published in: Current Pulmonology Reports | Issue 4/2015

Login to get access

Abstract

Traditionally recognized smoking-related lung diseases include chronic obstructive pulmonary disease (COPD), respiratory bronchiolitis/interstitial lung disease, desquamative interstitial pneumonitis, and pulmonary Langerhans cell histiocytosis. More recently described smoking-related entities include combined pulmonary fibrosis and emphysema and respiratory bronchiolitis with fibrosis. We review the important past and current literature pertaining to these diseases, including recent developments in quantitative imaging of COPD and in CT characterization of smoking-related fibrosis.
Literature
1.
2.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.
3.
Franks TJ, Galvin JR. Smoking-related “interstitial” lung disease. Arch Pathol Lab Med. 2015;139(8):974–7.CrossRefPubMed
4.
Hansell DM, Nicholson AG. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin Respir Crit Care Med. 2003;24(4):377–92.CrossRefPubMed
5.
Walsh SLF, Nair A, Desai SR. Interstitial lung disease related to smoking. Curr Opin Pulm Med. 2015;21(4):407–16.CrossRefPubMed
6.
Nishio M, Matsumoto S, Koyama H, Yoshikawa T, Sugihara N, Sugimura K, et al. Emphysema quantification by combining percentage and size distribution of low-attenuation lung regions. Am J Roentgenol. 2014;202:W453–8.CrossRef
7.
Coxson HO, Rogers RM. Quantitative computed tomography of chronic obstructive pulmonary disease. Acad Radiol. 2005;12(11):1457–63.CrossRefPubMed
8.
Van Tho N, Wada H, Ogawa E, Nakano Y. Recent findings in chronic obstructive pulmonary disease by using quantitative computed tomography. Respir Investig. 2012;50(3):78–87.
9.••
Lynch DA, Austin JHM, Hogg JC, Grenier PA, Kauczor H, Bankier AA, et al. CT-Definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner society. Radiology. 2015. Epub. doi: 10.​1148/​radiol.​2015141579. Proposes a standardized scheme for describing morphologic phenotypes of emphysema detected at computed tomography. Provides a basis for correlation of CT subtypes and functional studies.
10.
Beasley MB. Smoking-related small airway disease—a review and update. Adv Anat Pathol. 2010;17(4):270–6.CrossRefPubMed
11.
Mohamed Hoesein FAA, Schmidt M, Mets OM, Gietema HA, Lammers JWJ, Zanen P, et al. Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD. Respir Med. 2014;108(1):136–43.CrossRefPubMed
12.
Mohamed Hoesein FAA, de Jong PA, Lammers JWJ, Mali WPTM, Mets OM, et al. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. COPD. 2014;11(5):503–9.CrossRefPubMed
13.••
Lynch DA, Al-Qaisi MA. Quantitative computed tomography in chronic obstructive pulmonary disease. J Thorac Imaging. 2013;28(5):284–90. Provides an overview of developments in the quantitative CT of COPD, with a focus on the technical aspects of lung attenuation measurement and airway measurement.
14.
Mohamed Hoesein FAA, de Hoop B, Zanen P, Gietema H, Kruitwagen CLJJ, van Ginneken B, et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax. 2011;66(9):782–7.CrossRefPubMed
15.
Haruna A, Muro S, Nakano Y, Ohara T, Hoshino Y, Ogawa E, et al. CT scan findings of emphysema predict mortality in COPD. Chest. 2010;138(3):635–40.CrossRefPubMed
16.
Stolk J, Putter H, Bakker EM, Shaker SB, Parr DG, Piitulainen E, et al. Progression parameters for emphysema: a clinical investigation. Respir Med. 2007;101(9):1924–30.CrossRefPubMed
17.
Tanabe N, Muro S, Hirai T, Oguma T, Terada K, Marumo S, et al. Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1653–9.CrossRefPubMed
18.
Camiciottoli G, Cavigli E, Grassi L, Diciotti S, Orlandi I, Zappa M, et al. Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial. Eur Radiol. 2009;19(1):58–66.CrossRefPubMed
19.
Grydeland TB, Dirksen A, Coxson HO, Pillai SG, Sharma S, Eide GE, et al. Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J. 2009;34(4):858–65.CrossRefPubMed
20.
Ashraf H, Lo P, Shaker SB, de Bruijne M, Dirksen A, Tønnesen P, et al. Short-term effect of changes in smoking behaviour on emphysema quantification by CT. Thorax. 2011;66(1):55–60.CrossRefPubMed
21.
Shaker SB, Stavngaard T, Laursen LC, Stoel BC, Dirksen A. Rapid fall in lung density following smoking cessation in COPD. COPD. 2011;8(1):2–7.CrossRefPubMed
22.•
Schroeder JD, McKenzie AS, Zach JA, Wilson CG, Curran-Everette D, Stinson DS, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. Am J Roentgenol. 2013;201:W460–70. Provides an example of the correlation of pulmonary function testing and quantitative CT measurements in patients with and without COPD.
23.
Sasaki T, Takahashi K, Takada N, Ohsaki Y. Ratios of peripheral-to-central airway lumen area and percentage wall area as predictors of severity of chronic obstructive pulmonary disease. Am J Roentgenol. 2014;203:78–84.CrossRef
24.
Yamashiro T, Matsuoka S, Estepar RS, Dransfield MT, Diaz A, Reilly JJ, et al. Quantitative assessment of bronchial wall attenuation with thin-section CT: an indicator of airflow limitation in chronic obstructive pulmonary disease. Am J Roentgenol. 2010;195:363–9.CrossRef
25.
Lederlin M, Laurent F, Dromer C, Cochet H, Berger P, Montaudon M. Mean bronchial wall attenuation value in chronic obstructive pulmonary disease: comparison with standard bronchial parameters and correlation with function. Am J Roentgenol. 2012;198:800–8.CrossRef
26.
Hackx M, Gyssels E, Garcia TS, De Meulder I, Alard S, Van Muylem A, et al. Chronic obstructive pulmonary disease: CT quantification of airway dimensions, numbers of airays to measure, and effect of bronchodilation. Radiology. 2015. Epub 5/19/2015.
27.
Hidalgo A, Franquet T, Gimenez A, Bordes R, Pineda R, Madrid M, et al. Smoking-related interstitial lung diseases: radiologic-pathologic correlation. Eur Radiol. 2006;16:2463–70.CrossRefPubMed
28.
Nemec SF, Eisenberg RL, Bankier AA. Noninfectious inflammatory lung disease: imaging considerations and clues to differential diagnosis. Am J Roentgenol. 2013;201:278–94.CrossRef
29.•
Nair A, Hansell DM. High-resolution computed tomography features of smoking-related interstitial lung disease. Semin Ultrasound CT MR. 2014;35:59–71. Reviews the major smoking-related interstitial lung diseases, with special attention to the overlapping features of these diseases at CT.
30.
Caminati A, Cavazza A, Sverzellati N, Harari S. An integrated approach in the diagnosis of smoking-related interstitial lung diseases. Eur Respir Rev. 2012;21(125):207–17.CrossRefPubMed
31.
Seaman DM, Meyer CA, Gilman MD, McCormack FX. Diffuse cystic lung disease at high-resolution CT. Am J Roentgenol. 2011;196:1305–11.CrossRef
32.
33.
Brauner MW, Grenier P, Tijani K, Battesti JP, Valeyre D. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology. 1997;204:497–502.CrossRefPubMed
34.
Rao RN, Goodman LR, Tomashefski JF. Smoking-related interstitial lung disease. Ann Diagn Pathol. 2008;12(6):445–57.CrossRefPubMed
35.
Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med. 1974;291(15):755–8.CrossRefPubMed
36.
Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol. 2002;26(5):647–53.CrossRefPubMed
37.
Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005;127(1):178–84.CrossRefPubMed
38.
Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA. Idiopathic interstitial pneumonias: CT features. Radiology. 2005;236(1):10–21.CrossRefPubMed
39.
Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax. 1999;54(11):1009–14.PubMedCentralCrossRefPubMed
40.
Wells AU, Nicholson AG, Hansell DM. Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax. 2007;62(10):904–10.PubMedCentralCrossRefPubMed
41.
42.
Park J, Brown K, Tuder R, Hale V, King Jr T, Lynch D. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr. 2002;26(1):13–20.
43.
Heyneman LE, Ward S, Lynch DA, Remy-Jardin M, Johkoh T, Muller NL. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? Am J Roentgenol. 1999;173(6):1617–22.
44.
Tazelaar HD, Wright JL, Churg A. Desquamative interstitial pneumonia. Histopathology. 2011;58(4):509–16.CrossRefPubMed
45.
Swartz JS, Chatterjee S, Parambil JG. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis. J Clin Rheumatol. 2010;16(6):284–6.CrossRefPubMed
46.
Esmaeilbeigi F, Juvet S, Hwang D, Mittoo S. Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus. Can Respir J. 2012;19(1):50–2.PubMedCentralPubMed
47.
Kroll RR, Flood DA, Srigley J. Desquamative interstitial pneumonitis in a non-smoker: a rare diagnosis. Can Respir J. 2014;21(2):86–8.PubMedCentralPubMed
48.
Godbert B, Wissler MP, Vignaud JM. Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology. Eur Respir Rev. 2013;22(128):117–23.CrossRefPubMed
49.
Carrington CB, Gaensler EA, Coutu RE. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med. 1978;298(15):801–9.CrossRefPubMed
50.
Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med. 1965;39:369–404.CrossRefPubMed
51.
52.
Sever-Chroneos Z, Murthy A, Davis J, Florence JM, Kurdowska A, Krupa A. GM-CSF modulates pulmonary resistance to influenza A infection. Antiviral Res. 2011;92(2):319–28.CrossRefPubMed
53.
Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc. 1989;64(11):1373–80.CrossRefPubMed
54.
Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G, Muller NL. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1993;187(3):787–90.CrossRefPubMed
55.
Kawabata Y, Takemura T, Hebisawa A, Sugita Y, Ogura T, Nagai S. Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically. Respirology. 2012;17(8):1214–21.CrossRefPubMed
56.
Vassallo R, Jensen EA, Colby TV, Ryu JH, Douglas WW, Hartman TE. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest. 2003;124(4):1199–205.CrossRefPubMed
57.
Auerbach O, Garfinkel L, Hammond EC. Relation of smoking and age to findings in lung parenchyma: a microscopic study. Chest. 1974;65(1):29–35.CrossRefPubMed
58.
59.••
Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H. Interstitial lung abrnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology. 2013;268(2):563–71. Highlights the relatively high rate of interstitial lung disease in a smoking population.
60.
Travis WD, Costabel U, Hansell DM, King TE, Jr., Lynch DA, Nicholson AG. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.
61.
Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;144(3 Pt 1):504–6.CrossRefPubMed
62.
Doherty MJ, Pearson MG, O’Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997;52(11):998–1002.PubMedCentralCrossRefPubMed
63.
Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–93.CrossRefPubMed
64.
Ye Q, Huang K, Ding Y, Lou B, Hou Z, Dai H, et al. Cigarette smoking contributes to idiopathic pulmonary fibrosis associated with emphysema. Chin Med J. 2014;127(3):469–74.PubMed
65.
Cottin V, Le Pavec J, Prevot G, Mal H, Humbert M, Simonneau G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010;35(1):105–11.CrossRefPubMed
66.
Girard N, Marchand-Adam S, Naccache JM, Borie R, Urban T, Jouneau S, et al. Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patients. J Thorac Oncol. 2014;9(8):1162–70.CrossRefPubMed
67.
68.
Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144(1):234–40.
69.
Rogliani P, Mura M, Mattia P, Ferlosio A, Farinelli G, Mariotta S, et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med. 2008;102(12):1753–61.
70.
Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990;84(5):365–9.CrossRefPubMed
71.
Grubstein A, Bendayan D, Schactman I. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med. 2005;99(8):948–54.CrossRefPubMed
72.
Kitaguchi Y, Fujimoto K, Hanaoka M. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 2010;15(2):265–71.CrossRefPubMed
73.
74.
American Thoracic S, European Respiratory S. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304.CrossRef
75.
Matsuoka S, Yamashiro T, Matsushita S, Kotoku A, Fujikawa A, Yagihashi K, et al. Quantitative CT evaluation in patients with combined pulmonary fibrosis and emphysema: correlation with pulmonary function. Acad Radiol. 2015;22:626–31.
76.
Kawabata Y, Hoshi E, Murai K, Ikeya T, Takahashi N, Saitou Y, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 2008;53(6):707–14.
77.
Katzenstein AL. Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol. 2013;66(10):882–7.CrossRefPubMed
78.
Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol. 2006;19(11):1474–9.PubMed
79.
Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol. 2010;41(3):316–25.CrossRefPubMed
80.•
English C, Churg A, Lam S, Bilawich AM. Respiratory bronchiolitis with fibrosis: prevalence and progression. Ann Am Thorac Soc. 2014;11(10):1665–6. Provides an overview of the relatively new entity of respiratory bronchiolitis with fibrosis, with a review of the recent literature on the topic.
81.
Watanabe Y, Kawabata Y, Kanauchi T, Hoshi E, Kurashima K, Koyama S, et al. Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol. 2015;84(5):986–92.
Metadata
Title
Computed tomography of smoking-related lung disease: review and update
Authors
Karen S. Zheng
Travis S. Henry
Brent P. Little
Publication date
01-12-2015
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 4/2015
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-015-0128-2

Other articles of this Issue 4/2015

Current Pulmonology Reports 4/2015 Go to the issue

Smoking Cessation (S. Veeraraghavan, Section Editor)

Waterpipe tobacco-smoking: a new smoking epidemic among the young?

Bronchiectasis (G Tino, Section Editor)

Inhaled antibiotics for bronchiectasis: are we there yet?

Bronchiectasis (G Tino, Section Editor)

Diagnostic approach to bronchiectasis

Smoking Cessation (S. Veeraraghavan, Section Editor)

Pharmacological therapies in smoking cessation: an evidence-based update
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits